113 related articles for article (PubMed ID: 34318822)
21. 3-octadecylcarbamoylacrylic acid-cisplatin nanocomplexes for the development of novel liposome formulation.
Song J; Xu T; Zhang Y; Guo H; Ren W; Zhu S; Yang L
Drug Deliv; 2016 Nov; 23(9):3285-3293. PubMed ID: 27028975
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of biocompatible polymeric nano-capsules based on calcium carbonate: A potential cisplatin delivery system.
Vergaro V; Papadia P; Leporatti S; De Pascali SA; Fanizzi FP; Ciccarella G
J Inorg Biochem; 2015 Dec; 153():284-292. PubMed ID: 26560986
[No Abstract] [Full Text] [Related]
23. Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation.
Tyagi M; Patro BS
Toxicol In Vitro; 2019 Oct; 60():125-133. PubMed ID: 31077746
[TBL] [Abstract][Full Text] [Related]
24. Ternary Nanocomposites Based on Oxidized Carbon Nanohorns as Sensing Layers for Room Temperature Resistive Humidity Sensing.
Serban BC; Cobianu C; Buiu O; Bumbac M; Dumbravescu N; Avramescu V; Nicolescu CM; Brezeanu M; Pachiu C; Craciun G; Radulescu C
Materials (Basel); 2021 May; 14(11):. PubMed ID: 34063918
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
26. Anthocyanins Isolated from
Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation into carbon nanotubes and release of anticancer Cisplatin drug molecule.
Mejri A; Vardanega D; Tangour B; Gharbi T; Picaud F
J Phys Chem B; 2015 Jan; 119(2):604-11. PubMed ID: 25514358
[TBL] [Abstract][Full Text] [Related]
30. Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity.
Velinova MJ; Staffhorst RW; Mulder WJ; Dries AS; Jansen BA; de Kruijff B; de Kroon AI
Biochim Biophys Acta; 2004 May; 1663(1-2):135-42. PubMed ID: 15157616
[TBL] [Abstract][Full Text] [Related]
31. How can the cisplatin analogs with different amine act on DNA during cancer treatment theoretically?
Rahiminezhad A; Moghadam ME; Divsalar A; Mesbah AW
J Mol Model; 2021 Dec; 28(1):2. PubMed ID: 34874466
[TBL] [Abstract][Full Text] [Related]
32. Polymeric micelles for pH-responsive delivery of cisplatin.
Shahin M; Safaei-Nikouei N; Lavasanifar A
J Drug Target; 2014 Aug; 22(7):629-37. PubMed ID: 24878378
[TBL] [Abstract][Full Text] [Related]
33. The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin.
Rivel T; Ramseyer C; Yesylevskyy S
Sci Rep; 2019 Apr; 9(1):5627. PubMed ID: 30948733
[TBL] [Abstract][Full Text] [Related]
34. Encapsulation of cisplatin as an anti-cancer drug into boron-nitride and carbon nanotubes: Molecular simulation and free energy calculation.
Roosta S; Hashemianzadeh SM; Ketabi S
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():98-103. PubMed ID: 27287103
[TBL] [Abstract][Full Text] [Related]
35. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.
Zhao Y; May JP; Chen IW; Undzys E; Li SD
Pharm Res; 2015 Oct; 32(10):3261-8. PubMed ID: 25964047
[TBL] [Abstract][Full Text] [Related]
36. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
37. Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles.
Zhen X; Wang X; Xie C; Wu W; Jiang X
Biomaterials; 2013 Jan; 34(4):1372-82. PubMed ID: 23158934
[TBL] [Abstract][Full Text] [Related]
38. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
Kates M; Date A; Yoshida T; Afzal U; Kanvinde P; Babu T; Sopko NA; Matsui H; Hahn NM; McConkey DJ; Baras A; Hanes J; Ensign L; Bivalacqua TJ
Clin Cancer Res; 2017 Nov; 23(21):6592-6601. PubMed ID: 28808039
[No Abstract] [Full Text] [Related]
39. Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.
Chen Q; Luo L; Xue Y; Han J; Liu Y; Zhang Y; Yin T; Wang L; Cun D; Gou J; He H; Tang X
Acta Biomater; 2019 Jul; 92():205-218. PubMed ID: 31071475
[TBL] [Abstract][Full Text] [Related]
40. Injectable Thermosensitive Polypeptide-Based CDDP-Complexed Hydrogel for Improving Localized Antitumor Efficacy.
Yu S; Zhang D; He C; Sun W; Cao R; Cui S; Deng M; Gu Z; Chen X
Biomacromolecules; 2017 Dec; 18(12):4341-4348. PubMed ID: 29141405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
